Gaviscon Peppermint Chewable Tablets provide relief from symptoms of gastro-oesophageal reflux, including heartburn, acid regurgitation and reflux-related indigestion. They combine sodium alginate with two antacids: the antacids neutralise excess stomach acid while sodium alginate forms a protective layer over the stomach contents to help reduce reflux. No water is required, making them a convenient option at any time.
Key Benefits
- Relieves heartburn and reflux-related indigestion
- Helps with acid regurgitation
- Forms a protective alginate barrier
- Antacids help neutralise excess stomach acid
- Convenient chewable format — no water required
- Peppermint flavour
- Suitable for adults and children aged 12 years+
- May be used during pregnancy and breastfeeding when taken as directed
- Convenient 48-tablet pack
Active Ingredients
Each chewable tablet contains:
- Sodium Alginate 250mg – Forms a protective raft over the stomach contents to help reduce reflux.
- Sodium Hydrogen Carbonate 133.5mg – An antacid that helps neutralise excess stomach acid and contributes to raft formation.
- Calcium Carbonate 80mg – Provides additional acid-neutralising action.
How to Use
- Thoroughly chew 2–4 tablets after meals and at bedtime, up to four times daily.
- Adults and children aged 12 years and over: 2–4 tablets after meals and at bedtime.
- Children under 12 years: Use only on medical advice.
- If symptoms do not improve after 7 days, seek medical advice.
Suitable For
Suitable for adults and children aged 12 years and over for the relief of heartburn, acid regurgitation and reflux-related indigestion. May be used during pregnancy and breastfeeding when taken as directed. Children under 12 years should only use on medical advice.
Pack Information
- Pack size: 48 chewable tablets
- Flavour: Peppermint
- Dosage form: Chewable tablets
- Active ingredients: Sodium Alginate 250mg + Sodium Hydrogen Carbonate 133.5mg + Calcium Carbonate 80mg per tablet
- Suitable age: 12 years+
- Irish licence: PA0979/015/004
- Licence holder: Reckitt Benckiser Ireland Limited
- Legal status: Non-prescription / general sale
Patient Information Leaflet
Please click here to access the Patient Information Leaflet
Warnings
- This product is high in sodium — relevant for people following a highly restricted salt diet.
- Contains aspartame (E951), a source of phenylalanine. Not suitable for people with phenylketonuria (PKU).
- Do not exceed the recommended dose.
- If symptoms persist beyond 7 days, seek medical advice.
- Keep out of the sight and reach of children.
Always read the current Patient Information Leaflet and product packaging before use.